Our predictive model, based on routine peripheral blood cell results at 20-24 weeks of gestation, could provide insight into earlier prediction of FGR occurrence in patients with PE, facilitating further fetal monitoring and clinical decision-making.
Li et al. (Wed,) studied this question.